Botulinum TOX TYP a 1S

Ended Awarded

Contract number
SPE2DR26FBUKM
Awardee
Awarding agency
Obligated
$37,430

Award facts

Contract value 100% obligated
$37,429.86 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $37,429.86 delivery order to DMS Pharmaceutical Group Inc. on June 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for Botulinum Toxin Type A 1S, with a firm fixed price and an ultimate completion date of June 29, 2026.

Place of performance is Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business serving as the sole regional prime vendor under PPV-G GEN V's single-award indefinite delivery contract with a $499.999 billion ceiling and a completion date of December 31, 2036. The order was issued without a set-aside designation.

Quick answers

Who was awarded contract SPE2DR26FBUKM?

SPE2DR26FBUKM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 12, 2026.

How much is contract SPE2DR26FBUKM worth?

The government has obligated $37,430 on SPE2DR26FBUKM.

Is contract SPE2DR26FBUKM an order under another contract?

Yes. SPE2DR26FBUKM is a delivery order under SPE2DR25D9628, an indefinite delivery contract.

Was contract SPE2DR26FBUKM competed?

The extent of competition for SPE2DR26FBUKM was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award